Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition
Go back to Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition| (NASDAQ: QTRX) | Delayed: 2.99 -0.13 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.12 | 52 Week High | $ | |||
| Open | $3.11 | 52 Week Low | $ | |||
| Day High | $3.11 | P/E | N/A | |||
| Day Low | $2.99 | EPS | $ | |||
| Volume | 323,156 | |||||

